Deutsche Bank’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-204,479
Closed -$8.11M 3691
2024
Q1
$8.11M Buy
204,479
+75,000
+58% +$2.97M ﹤0.01% 1087
2023
Q4
$2.47M Buy
129,479
+111,968
+639% +$2.13M ﹤0.01% 1552
2023
Q3
$201K Sell
17,511
-109,814
-86% -$1.26M ﹤0.01% 2762
2023
Q2
$1.31M Buy
127,325
+112,574
+763% +$1.16M ﹤0.01% 1838
2023
Q1
$114K Buy
14,751
+6,596
+81% +$50.9K ﹤0.01% 3264
2022
Q4
$59.9K Buy
8,155
+106
+1% +$779 ﹤0.01% 3500
2022
Q3
$58K Sell
8,049
-1,040
-11% -$7.49K ﹤0.01% 3515
2022
Q2
$77K Buy
9,089
+2,789
+44% +$23.6K ﹤0.01% 3595
2022
Q1
$57K Sell
6,300
-742
-11% -$6.71K ﹤0.01% 3720
2021
Q4
$98K Buy
7,042
+362
+5% +$5.04K ﹤0.01% 3656
2021
Q3
$71K Sell
6,680
-127,377
-95% -$1.35M ﹤0.01% 3921
2021
Q2
$1.21M Sell
134,057
-110,275
-45% -$993K ﹤0.01% 2643
2021
Q1
$2.59M Buy
+244,332
New +$2.59M ﹤0.01% 1970
2020
Q1
Sell
-1,065
Closed -$4K 4620
2019
Q4
$4K Buy
+1,065
New +$4K ﹤0.01% 4456
2019
Q1
Sell
-405
Closed -$1K 4901
2018
Q4
$1K Sell
405
-33,858
-99% -$83.6K ﹤0.01% 4626
2018
Q3
$217K Sell
34,263
-6,405
-16% -$40.6K ﹤0.01% 4101
2018
Q2
$308K Buy
40,668
+2,988
+8% +$22.6K ﹤0.01% 4000
2018
Q1
$301K Buy
37,680
+20,388
+118% +$163K ﹤0.01% 3887
2017
Q4
$193K Sell
17,292
-4,930
-22% -$55K ﹤0.01% 3879
2017
Q3
$257K Buy
22,222
+21,922
+7,307% +$254K ﹤0.01% 3633
2017
Q2
$2K Buy
+300
New +$2K ﹤0.01% 4385
2016
Q4
Sell
-2,822
Closed -$91K 4546
2016
Q3
$91K Sell
2,822
-1,494
-35% -$48.2K ﹤0.01% 3773
2016
Q2
$79K Buy
4,316
+4,132
+2,246% +$75.6K ﹤0.01% 4007
2016
Q1
$3K Sell
184
-126
-41% -$2.05K ﹤0.01% 4627
2015
Q4
$9K Sell
310
-37
-11% -$1.07K ﹤0.01% 4504
2015
Q3
$18K Buy
347
+178
+105% +$9.23K ﹤0.01% 4402
2015
Q2
$10K Buy
+169
New +$10K ﹤0.01% 4593